Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults
Clinical trial NCT06429930 · RECRUITING
Trial details
- NCT number
- NCT06429930
- Sponsor
- Pharmosa Biopharm Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-11
- Primary completion
- 2026-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.